WASHINGTON, April 27 /PRNewswire-USNewswire/ — Lung Cancer Alliance announced that a comprehensive lung cancer research funding bill targeting lung cancer‘s high mortality rate was introduced with bipartisan support today in the U.S. House of Representatives today.

“We now have legislation authorizing a broad new comprehensive, multi-agency approach to lung cancer in both Houses of Congress. This is a milestone — the turning point we are all looking for in federal policy on lung cancer,” said LCA President and CEO Laurie Fenton Ambrose.